レコードの引用形

APA(7版)引用形式
Taniguchi, T., Iinuma, K., Kawada, K., Ishida, T., Takagi, K., Tomioka, M., . . . Koie, T. (2024). Real-World Oncological Outcomes of Nivolumab Plus Ipilimumab in Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study in Japan. MDPI AG.
Chicagoスタイル(17版)引用形式
Taniguchi, Tomoki, et al. Real-World Oncological Outcomes of Nivolumab Plus Ipilimumab in Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study in Japan. MDPI AG, 2024.
MLA(9版)引用形式
Taniguchi, Tomoki, et al. Real-World Oncological Outcomes of Nivolumab Plus Ipilimumab in Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study in Japan. MDPI AG, 2024.
警告: この引用は必ずしも正確ではありません.